Depression Clinical Trials in Baltimore, MD

53 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
ALTO-100 in Bipolar Disorder With Depression (BD-D)	Phase 2	Alto Neuroscience	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
CAPABLE Transplant	N/A	Johns Hopkins University	<1 mi
Glucose Variability and Cognition in Prediabetes	—	University of Maryland, Baltimore	<1 mi
Defining Neurobiological Links Between Substance Use and Mental Illness	N/A	National Institute on Drug Abuse (NIDA)	<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study	N/A	Johns Hopkins University	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Identification and Validation of Epigenetic Biomarkers of PMDD	—	Johns Hopkins University	<1 mi
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder	Phase 4	Johns Hopkins University	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	<1 mi
Preventing Postpartum Depression in Immigrant Latinas	N/A	Northwestern University	<1 mi
Psilocybin in Chronic Low Back Pain and Depression	Phase 1	Johns Hopkins University	<1 mi
Advanced Prediction of Respiratory Depression Episode Using the Linshom Continuous Predictive Respiratory Sensor	—	Linshom Medical, Inc.	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease	Early 1	Johns Hopkins University	<1 mi
VR-PMR for Post-Burn Symptoms	N/A	Johns Hopkins University	<1 mi
Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention	N/A	Johns Hopkins Bloomberg School of Public Health	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	8 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	8 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	8 mi
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders	Phase 2	National Institute of Mental Health (NIMH)	28 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	32 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	33 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	33 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder	Phase 2	Janssen Research & Development, LLC	33 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	33 mi
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET	Phase 1	National Institute of Mental Health (NIMH)	34 mi
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder	Phase 1	National Institute of Mental Health (NIMH)	34 mi
Characterization and Treatment of Adolescent Depression	—	National Institute of Mental Health (NIMH)	34 mi
Long-term Observation of Participants With Mood Disorders	—	National Institute of Mental Health (NIMH)	34 mi
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms	N/A	Johns Hopkins University	34 mi
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder	—	National Institute of Mental Health (NIMH)	34 mi
Neurobiology of Suicide	Phase 2	National Institute of Mental Health (NIMH)	34 mi
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)	Phase 1	National Institute of Mental Health (NIMH)	34 mi
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression	Phase 2	National Institute of Mental Health (NIMH)	34 mi
Natural History of Depression, Bipolar Disorder and Suicide Risk	—	National Institute of Mental Health (NIMH)	34 mi
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression	Phase 1	National Institute of Mental Health (NIMH)	34 mi
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers	—	National Institute of Mental Health (NIMH)	34 mi
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV	Phase 2	National Institute of Allergy and Infectious Diseases (NIAID)	36 mi
The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic	N/A	Children's National Research Institute	36 mi
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method	N/A	Georgetown University	36 mi
Mindful Self-Compassion for Anxiety Disorders and Depression	N/A	Georgetown University	36 mi
Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes	N/A	Children's National Research Institute	36 mi
Does Social Media Impact Adolescent Mental Health?	N/A	Georgetown University	36 mi
Clinical Validation of a Predictive Test for Postpartum Depression	—	University of Virginia	41 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	48 mi
rTMS for Military TBI-related Depression	N/A	Henry M. Jackson Foundation for the Advancement of Military Medicine	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.